,outcome,arm 1,arm 2
0,intervention,"amantadine -6.4, amantadine-treated group",placebo -2.1
0,,amantadine -6.4,NR
0,"inappropriate speech, hyperactivity",-1.9,NR
0,"inappropriate speech, hyperactivity, absolute changes in clinician-rated ABC-CVs",NR,0.4
